Cartesian Therapeutics In... (RNAC)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
19.13
1.11 (6.16%)
At close: Jan 15, 2025, 3:59 PM
19.50
1.93%
After-hours Jan 15, 2025, 04:08 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
Cash & Equivalents | 76.91M | 106.44M | 114.06M | 138.69M | 90.17M | 37.40M | 70.70M | 58.73M | 32.47M | 16.59M |
Short-Term Investments | n/a | 28.16M | 14.00M | n/a | n/a | n/a | 25.94M | 25.48M | 4.13M | n/a |
Long-Term Investments | 2.00M | 2.00M | 2.00M | 1.75M | 1.38M | 279.00K | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 1.38M | 1.34M | 1.47M | n/a | n/a | -1 | 329.00K | 438.00K | 1.88M | 1.13M |
Receivables | 8.85M | 9.86M | 9.91M | 7.22M | 5.00M | n/a | 63.00K | 215.00K | 824.00K | 674.00K |
Inventory | n/a | n/a | n/a | 1.00M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 4.97M | 3.39M | 6.47M | 5.43M | 1.77M | 4.67M | 4.02M | 2.46M | 1.63M | 1.85M |
Total Current Assets | 90.73M | 148.14M | 144.44M | 151.34M | 96.67M | 42.08M | 98.68M | 86.82M | 38.91M | 19.11M |
Property-Plant & Equipment | 12.18M | 14.41M | 11.97M | 12.34M | 1.52M | 2.13M | 2.09M | 2.05M | 2.03M | 1.98M |
Goodwill & Intangibles | 198.76M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 214.32M | 17.75M | 15.44M | 14.09M | 2.90M | 2.41M | 2.42M | 2.48M | 3.91M | 3.12M |
Total Assets | 305.05M | 165.89M | 159.88M | 165.44M | 99.57M | 44.48M | 101.10M | 89.30M | 42.82M | 22.23M |
Account Payables | 3.15M | 316.00K | 224.00K | 443.00K | 500.00K | 1.10M | 1.61M | 3.88M | 2.18M | 351.00K |
Deferred Revenue | 2.31M | 593.00K | 53.88M | 72.05M | 1.67M | 959.00K | 787.00K | 1.84M | 1.31M | 3.02M |
Short-Term Debt | 2.17M | 10.08M | 7.01M | 908.00K | 19.28M | 21.39M | n/a | 4.07M | n/a | 2.58M |
Other Current Liabilities | 60.58M | 23.93M | 17.89M | 8.15M | 24.75M | 11.70M | 8.58M | 3.92M | 3.80M | 3.28M |
Total Current Liabilities | 68.21M | 25.08M | 72.25M | 81.55M | 34.94M | 35.14M | 10.97M | 13.71M | 7.29M | 9.23M |
Long-Term Debt | -313.29M | 27.84M | 28.27M | 34.44M | n/a | n/a | 21.04M | 7.98M | 11.86M | 4.82M |
Other Long-Term Liabilities | 342.62M | 19.14M | 25.42M | 28.71M | 41.55M | 938.00K | 1.35M | 222.00K | 395.00K | 94.56M |
Total Long-Term Liabilities | 677.02M | 46.98M | 65.11M | 101.89M | 56.23M | 14.76M | 38.31M | 20.64M | 14.54M | 100.75M |
Total Liabilities | 745.23M | 72.06M | 137.36M | 183.44M | 91.17M | 49.90M | 49.29M | 34.34M | 21.84M | 109.98M |
Total Debt | 10.96M | 37.92M | 35.28M | 35.35M | 19.28M | 21.39M | 21.04M | 12.04M | 11.86M | 7.40M |
Common Stock | 16.00K | 15.00K | 12.00K | 11.00K | 9.00K | 3.00K | 3.00K | 1K | n/a | n/a |
Retained Earnings | -614.65M | -394.94M | -430.32M | -404.63M | -335.75M | -280.40M | -216.90M | -151.58M | -111.51M | -83.88M |
Comprehensive Income | -4.60M | -4.56M | -4.57M | -4.56M | -4.52M | -4.56M | -4.42M | -4.59M | -4.99M | -3.88M |
Shareholders Equity | -440.18M | 93.83M | 22.52M | -18.01M | 8.40M | -5.42M | 51.81M | 54.96M | 20.99M | -87.75M |
Total Investments | 2.00M | 30.16M | 16.00M | 1.75M | 1.38M | 279.00K | 25.94M | 25.48M | 4.13M | n/a |